Winton Group LTD Verastem, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$2.05 - $3.2 $57,748 - $90,144	-28,170 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$2.54 - $4.07 $47,924 - $76,792	-18,868 Reduced 40.11%	28,170 $87,000
Q2 2021 Aug 10, 2021	SELL	$2.57 - $4.85 $32,168 - $60,707	-12,517 Reduced 21.02%	47,038 $191,000
Q1 2021 Jul 21, 2021	BUY	$1.9 - $2.82 $66,277 - $98,370	34,883 Added 141.39%	59,555 $147,000
Q4 2020 Feb 12, 2021	BUY	$1.15 - $2.4 $28,372 - $59,212	24,672 New	24,672 $53,000
Q4 2019 Feb 13, 2020	SELL	$0.86 - $1.44 $128,627 - $215,376	-149,567 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$1.21 - $1.59 $156,190 - $205,241	129,083 Added 630.17%	149,567 $181,000
Q2 2019 Jul 08, 2019	SELL	$1.25 - $3.14 $9,141 - $22,962	-7,313 Reduced 26.31%	20,484 $31,000
Q1 2019 May 13, 2019	BUY	$2.79 - $4.09 $77,553 - $113,689	27,797 New	27,797 $82,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.12B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.